Researchers with INSERM in Paris have detailed their development of a new vaccine strategy that shows promise for treating inflammatory bowel diseases like Crohn’s disease, as well as metabolic conditions like obesity. Key to the vaccine’s potential effectiveness is gut microbiota, abnormalities of which have been linked to a variety of health conditions. The new vaccine works by modifying these bacteria to protect the intestinal wall.